Skip to main content

Animations

MJFF Publications

6801 - 6810 of 8808 Results
Title
Year
  • Year
  • 2019
  • 2021
  • 2019
  • 2016
  • 2016
  • 2023
  • 2023
  • 2016
  • 2023
  • 2019
  • Summary Details
    OPEN
    Title: An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.02.023
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.006
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Bundled Three-Dimensional Human Axon Tracts Derived from Brain Organoids
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.isci.2019.10.004
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00036
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.08.023
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease
    Journal Name: Pharmaceuticals
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ph16060883
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Lack of significant Lewy pathology in 237 essential tremor brains
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/jnen/nlad022
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson’s Disease
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-161031
    Citation Count: 14
  • Summary Details
    OPEN
    Title: RTP801 mediates transneuronal toxicity in culture via extracellular vesicles
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/jev2.12378
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Driving genotype treatment options down the right path(way)
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27893
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.